Also find us on Mendeley:


Year: 2013

  • I. K. Astakhova, K. Pasternak, M. A. Campbell, P. Gupta and J. Wengel. "A locked nucleic acid-based nanocrawler: Designed and reversible movement detected by multicolor fluorescence", Journal of the American Chemical Society, Vol. 135. 2013, pp. 2423-2426. [More]
  • C. Bjerre et al. "Association of tissue inhibitor of metalloproteinases-1 and Ki67 in estrogen receptor positive breast cancer.", Acta oncologica (Stockholm, Sweden), Vol. 52. 2013, pp. 82-90. [More] [Online version]
  • K. E. Lundin et al. "Biological Activity and Biotechnological Aspects of Locked Nucleic Acids", Advances in Genetics, Vol. 82. 2013, pp. 47-107. [More]
  • M. B. Lyng et al. "Gene Expression Signatures That Predict Outcome of Tamoxifen-Treated Estrogen Receptor-Positive, High-Risk, Primary Breast Cancer Patients: A DBCG Study", PLoS ONE, Vol. 8. 2013. [More]
  • J. Madsen et al. "A Variant Form of the Human Deleted in Malignant Brain Tumor 1 (DMBT1) Gene Shows Increased Expression in Inflammatory Bowel Diseases and Interacts with Dimeric Trefoil Factor 3 (TFF3)", PLoS ONE, Vol. 8. 2013. [More]
  • H. Müller et al. "Cardiac amyloidosis induces up-regulation of Deleted in Malignant Brain Tumors 1 (DMBT1)", Cardiovascular Pathology, Vol. 22. 2013, pp. 195-202. [More] [Online version]
  • B. B. Olsen et al. "Novel radioisotope-based nanomedical approaches", European Journal of Nanomedicine, Vol. 5. 2013. [More] [Online version]
  • A. Reichold, S. A. Brenner, K. Förster-Fromme, I. Bergheim, J. Mollenhauer and S. C. Bischoff. "Dmbt1 does not affect a Western style diet-induced liver damage in mice", Journal of Clinical Biochemistry and Nutrition, Vol. 53. 2013, pp. 145-149. [More] [Online version]
  • M. Maru\v{s}i\v{c}, R. N. Veedu, J. Wengel and J. Plavec. "G-rich VEGF aptamer with locked and unlocked nucleic acid modifications exhibits a unique G-quadruplex fold", Nucleic Acids Research, Vol. 41. 2013, pp. 9524-9536. [More]
  • M. Thomassen, Q. Tan, M. Burton and T. A. Kruse. "Gene expression meta-analysis identifies cytokine pathways and 5q aberrations involved in metastasis of ERBB2 amplified and basal breast cancer", Cancer Informatics, Vol. 12. 2013, pp. 203-219. [More]
  • K. P. Rensen et al. "Long non-coding RNA HOTAIR is an independent prognostic marker of metastasis in estrogen receptor-positive primary breast cancer", Breast Cancer Research and Treatment, Vol. 142. 2013, pp. 529-536. [More]
  • M. G. Terp et al. "Anti-human CD73 monoclonal antibody inhibits metastasis formation in human breast cancer by inducing clustering and internalization of CD73 expressed on the surface of cancer cells.", Journal of immunology (Baltimore, Md. : 1950), Vol. 191. 2013, pp. 4165-73. [More] [Online version]

Year: 2012

  • A. Arouri and O. G. Mouritsen. "Phospholipase A(2)-susceptible liposomes of anticancer double lipid-prodrugs.", European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, Vol. 45, Mar, 2012, pp. 408-20. [More] [Online version]
  • M. F. Gjerstorff et al. "GAGE Cancer-Germline Antigens Are Recruited to the Nuclear Envelope by Germ Cell-Less (GCL", PLoS ONE, Vol. 7. 2012. [More]
  • K. H. Gravgaard et al. "The miRNA-200 family and miRNA-9 exhibit differential expression in primary versus corresponding metastatic tissue in breast cancer.", Breast cancer research and treatment, Feb, 2012. [More] [Online version]
  • T. Højland, R. N. Veedu, B. Vester and J. Wengel. "Enzymatic synthesis of DNA strands containing α-L-LNA ($\alpha$-L-configured locked nucleic acid) thymine nucleotides", Artificial DNA: PNA and XNA, Vol. 3. 2012, pp. 14-21. [More]
  • H. Jespersen, J. H. Andersen, H. J. Ditzel and O. G. Mouritsen. "Lipids, curvature stress, and the action of lipid prodrugs: free fatty acids and lysolipid enhancement of drug transport across liposomal membranes.", Biochimie, Vol. 94, Jan, 2012, pp. 2-10. [More] [Online version]
  • E. Kaemmerer et al. "Increased levels of deleted in malignant brain tumours 1 (DMBT1) in active bacteria-related appendicitis.", Histopathology, Vol. 60, Mar, 2012, pp. 561-9. [More] [Online version]
  • K. K. Karlsen, A. Pasternak, T. B. Jensen and J. Wengel. "Pyrene-modified unlocked nucleic acids: synthesis, thermodynamic studies, and fluorescent properties.", Chembiochem : a European journal of chemical biology, Vol. 13, Mar, 2012, pp. 590-601. [More] [Online version]
  • R. Leth-Larsen et al. "Functional heterogeneity within the CD44 high human breast cancer stem cell-like compartment reveals a gene signature predictive of distant metastasis.", Molecular medicine (Cambridge, Mass.), Vol. 18. 2012, pp. 1109-21. [More] [Online version]
  • R. R. Lund, M. G. Terp, A. V. Lænkholm, O. N. Jensen, R. Leth-Larsen and H. Ditzel. "Quantitative proteomics of primary tumors with varying metastatic capabilities using stable isotope-labeled proteins of multiple histogenic origins", Proteomics, Vol. 12. 2012, pp. 2139-2148. [More]
  • M. B. Lyng, A. V. Nkholm, R. Søkilde, K. H. Gravgaard, T. Litman and H. J. Ditzel. "Global microRNA expression profiling of high-risk ER+ breast cancers from patients receiving adjuvant Tamoxifen mono-therapy: A DBCG study", PLoS ONE, Vol. 7. 2012. [More]
  • J. B. Moeller et al. "CD163-L1 is an endocytic macrophage protein strongly regulated by mediators in the inflammatory response.", Journal of immunology (Baltimore, Md. : 1950), Vol. 188, Mar, 2012, pp. 2399-409. [More] [Online version]
  • J. Mollenhauer et al. "Breast cancer stem cells: a moving target for cancer nanomedicine", European Journal of Nanomedicine, Vol. 4, Jan, 2012, pp. 59-72. [More] [Online version]
  • H. Müller et al. "Deleted in malignant brain tumors 1 is present in the vascular extracellular matrix and promotes angiogenesis.", Arteriosclerosis, thrombosis, and vascular biology, Vol. 32, Feb, 2012, pp. 442-8. [More] [Online version]
Results 26 - 50 of 78




Joomla Templates by